MyFinsight
Home
About
Contact
eslaw: the income statement
Download
Download image
Net loss
-$4,801,149
Loss before income
taxes
-$4,801,149
Loss from operations
-$4,801,149
Total operating
expenses
$4,801,149
General and
administrative
$648,507
Research and development
$4,152,642
Back
Back
Income Statement
source: myfinsight.com
Estrella Immunopharma, Inc. (ESLAW)
Estrella Immunopharma, Inc. (ESLAW)